↓ Skip to main content

Dove Medical Press

Mitigation of MAFLD in High Fat-High Sucrose-Fructose Fed Mice by a Combination of Genistein Consumption and Exercise Training

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, July 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
22 Mendeley
Title
Mitigation of MAFLD in High Fat-High Sucrose-Fructose Fed Mice by a Combination of Genistein Consumption and Exercise Training
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, July 2022
DOI 10.2147/dmso.s358256
Pubmed ID
Authors

Chaheyla R St Aubin, Amy L Fisher, Jose A Hernandez, Tom L Broderick, Layla Al-Nakkash

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 2 9%
Student > Master 2 9%
Student > Postgraduate 2 9%
Other 1 5%
Student > Ph. D. Student 1 5%
Other 3 14%
Unknown 11 50%
Readers by discipline Count As %
Medicine and Dentistry 3 14%
Sports and Recreations 3 14%
Nursing and Health Professions 2 9%
Unspecified 1 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Other 0 0%
Unknown 12 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 August 2022.
All research outputs
#8,618,954
of 25,584,565 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#350
of 1,182 outputs
Outputs of similar age
#159,001
of 440,837 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#9
of 44 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,182 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,837 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 44 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.